|
|||||
|
|
Dramatic improvement after rituximab in a patient with paraneoplastic treatment‐refractory Morvan syndrome associated with anti‐CASPR2 antibodies |
|
| Authors: | E. Ong A. Viaccoz F. Ducray M. Pérol G. Cavillon V. Rogemond J. Honnorat P. Petiot |
| Affiliation: | 1. Centre de Référence Maladies Rares ‘Syndromes Neurologiques Paranéoplasiques’ Hospices Civils de Lyon, , Bron, France;2. Department of Pneumology, Hopital de la Croix Rousse, Hospices Civils de Lyon, , Lyon, France;3. Department of Neurology, Hopital de la Croix Rousse, Hospices Civils de Lyon, , Lyon, France |
| Abstract: | |
| Keywords: | anti‐CASPR2 antibodies Morvan syndrome paraneoplastic rituximab thymoma |